You may recognize brand names such as Ozempic, Wegovy, Mounjaro and Zepbound
Concurrent lifestyle modifications substantially influence results
This evidence gap reinforces the recommendation to discontinue GLP-1 therapy during the breastfeeding period
Analysis of specific topic This literature review was conducted following the PICO Framework, with details available in Supplementary material 1
We invite you to join our webinar titled GLP-1 Drugs: Whats Next after FDAs Resolution of Drug Shortages on December 4, 2024 to learn more about these issues
Abstract Cardiovascular-Kidney-Metabolic (CKM) syndrome, a newly defined systemic disorder, is characterized by the pathological interplay among diabetes, chronic kidney disease (CKD), and cardiovascular disease (CVD)